Risk assessment of chronic exposure to magnetic fields near electrical apparatus

The paper presents a numerical model to calculate ELF magnetic fields for typical conductor arrangements of electrical power lines. After an introduction to the problems arising from the exposure of human beings to low frequency magnetic fields, a description of the numerical model for the magnetic field evaluation is presented, discussing its application and presenting some examples. The attention is then devoted to the analysis of possible solutions for magnetic field reduction.

[1]  D A Savitz,et al.  Breast cancer mortality among female electrical workers in the United States. , 1994, Journal of the National Cancer Institute.

[2]  Alexander Mamishev,et al.  Effects of conductor sag on spatial distribution of power line magnetic field , 1996 .

[3]  J. Kaprio,et al.  Magnetic fields of transmission lines and depression. , 1997, American journal of epidemiology.

[4]  R. Turri,et al.  Accurate Calculation of the Right-of-Waywidth for Power Line Magnetic Field Impact Assessment , 2012 .

[5]  R. Rendina,et al.  Technical solutions to reduce 50 Hz magnetic fields from power lines , 2003, 2003 IEEE Bologna Power Tech Conference Proceedings,.

[6]  Robert Winker,et al.  Chromosomal damage in human diploid fibroblasts by intermittent exposure to extremely low-frequency electromagnetic fields. , 2005, Mutation research.

[7]  Per Gustavsson,et al.  Occupational exposure to extremely low frequency magnetic fields and mortality from cardiovascular disease. , 2003, American journal of epidemiology.

[8]  E. Robert.  Birth defects and high voltage power lines: an exploratory study based on registry data. , 1993, Reproductive toxicology.

[9]  A. Sastre,et al.  Magnetic field exposure and cardiovascular disease mortality among electric utility workers. , 1999, American journal of epidemiology.

[10]  Cindy Sage,et al.  Biological effects from electromagnetic field exposure and public exposure standards. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.